Oncotarget cover image

Genetic Study Identifies Potential Diagnostic Marker for Rare Blood Cancer BPDCN

Oncotarget

00:00

CCDC50 as a Potential Diagnostic Marker

Speaker 0 highlights CCDC50's high expression in BPDCN versus AML/CMML and its decline with treatment response.

Play episode at 02:21
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app